Logo
Arielle 2.7ml – 54mg HA

Arielle 2.7ml – 54mg HA

Arielle

Skin booster
  • CE Marked sterile absorbable hyaluronic acid dermal filler (93/42/EEC medical device classification as indicated in the manufacturer’s technical document).
  • Approved as a medical device in South Korea according to the manufacturer’s summary.
  • Manufactured by BioPlus Co., Ltd., a company specialising in medical biomaterials and hyaluronic acid Based products with established quality and regulatory frameworks.
Cross-linked hyaluronic acid hydro-lifting dermal filler

Description

Arielle 2.7ml – 54mg HA is a 5th-generation skin booster and hydro-lifting dermal filler containing hyaluronic acid of the purest origin. Formulated with a high concentration of low/minimally cross-linked hyaluronic acid (20 mg/ml, 2.7 ml per syringe), it is designed to revitalise the skin of the face, neck and hands, deeply moisturise dry skin and refresh the complexion at any age. The stable HA architecture provides a lifting effect, stimulates collagen synthesis, enhances dermal remodeling and strengthens the skin barrier, leading to improved elasticity, hydration and fine-wrinkle reduction. Arielle is injected intradermally using multiple bolus techniques to achieve powerful moisturisation, elasticity improvement, wrinkle correction and overall skin regeneration with a hydro-lifting effect. It is a CE-marked, sterile absorbable hyaluronic acid dermal filler intended strictly for professional use.

Bnefits

  • Delivers deep, long-lasting hydration to dry and ageing skin
  • Provides a hydro-lifting effect through stable cross-linked HA architecture
  • Stimulates collagen synthesis, supporting dermal firmness and elasticity
  • Improves dermal remodeling and repair processes
  • Helps reduce the appearance of fine lines and wrinkles
  • Strengthens the skin barrier and supports overall skin quality
  • Enhances skin elasticity and texture on the face, neck and hands
  • High cohesion and viscosity allow good product moulding and placement after injection
  • Minimised injection volume with maximised effectiveness thanks to high HA concentration
  • CE-marked sterile absorbable hyaluronic acid dermal filler from a recognised manufacturer

Indications

  • Revitalisation of the skin on the face, neck and hands
  • Moisturising and refreshing dry or dehydrated skin
  • Improvement of skin elasticity and texture
  • Correction and softening of fine lines and wrinkles
  • General skin rejuvenation and anti-ageing treatments
  • Hydro-lifting of lax or tired-looking skin
  • Enhancement of skin quality in photo-aged or chronologically aged skin

Composition

  • Hyaluronic acid 20 mg/ml (low/minimally cross-linked)
  • Total hyaluronic acid per syringe: 54 mg in 2.7 ml
  • Physiological buffer and excipients suitable for intradermal injection (as per official IFU; no additional active ingredients are listed in public sources)

Formulation

  • Sterile, pyrogen-free, absorbable hyaluronic acid dermal filler
  • Low/minimally cross-linked hyaluronic acid hydrogel with stable HA architecture
  • High cohesion and viscosity for controlled placement and lifting effect
  • Intended for intradermal injection by qualified healthcare professionals only

Packaging

  • Box containing 1 pre-filled syringe with a capacity of 2.7 ml
  • Single-use, disposable sterile medical device (do not reuse)
  • Supplied as a CE-marked hyaluronic acid dermal filler for professional use

Usage

  • Professional-use only: Arielle must be administered exclusively by qualified medical/aesthetic practitioners familiar with dermal filler and skin booster techniques.
  • Indications and areas: Designed to revitalise and hydrate skin on the face, neck and hands; also suitable for fine wrinkle improvement in targeted areas as per practitioner judgement.
  • Route of administration: Intradermal injection using a short needle (e.g. 34G, ~1.8 mm) according to the manufacturer’s use guide.
  • Face protocol: Multiple bolus injections at 12 defined facial points, injecting approximately 0.2 ml per point to achieve hydro-lifting and fine-wrinkle improvement.
  • Neck protocol: 10–15 injection points in the dermis of the neck, typically 0.1–0.2 ml per point, placed with attention to horizontal neck lines and avoidance of visible vessels.
  • Hands protocol: 10–12 injection points on each hand, injecting about 0.1 ml per point in the dermis, spaced roughly 1.5 cm apart and avoiding blood vessels.
  • Treatment course: A minimum of 2–3 treatment sessions is usually recommended, spaced at intervals of about 1 month between sessions, with dosing adjusted according to skin condition and practitioner judgement.
  • Maintenance: After completion of the initial series, a full treatment cycle is generally recommended every 3–6 months to maintain skin elasticity and results, with timing tailored to the individual.
  • Injection technique: Use vertical or angled needle insertion as per the anatomical area (e.g. vertical to 60° in the face, vertical in the neck, 60° to 30° in the hands), injecting in the dermis and avoiding intravascular injection.
  • Safety: Practitioners should review and follow the full instructions for use (IFU), adhere to aseptic technique, and evaluate contraindications and patient suitability before treatment.

Contraindications

  • Use by non-medical or inadequately trained personnel
  • Known hypersensitivity or allergy to hyaluronic acid or any excipient in the formulation
  • Presence of active skin infection, inflammation or disease at or near the injection site
  • History of severe allergy or anaphylactic reactions to injectable hyaluronic acid fillers, at the clinician’s discretion
  • General contraindications applicable to intradermal HA fillers and skin boosters as listed in the official instructions for use (e.g. certain autoimmune conditions, uncontrolled systemic disease, and other conditions as per local regulations and IFU)

Adverse Effects

  • As with other intradermal hyaluronic acid fillers, potential common adverse reactions include transient redness, swelling, tenderness, pain, bruising or itching at the injection sites.
  • Less common risks may include nodules, local inflammatory reactions, infection, or other complications if injection technique or asepsis is inadequate.
  • Practitioners are advised to consult and follow the contraindications, warnings and adverse reaction information in the official instructions for use and to manage complications according to standard clinical protocols.

Storage Conditions

  • Store in accordance with the instructions on the original packaging and IFU.
  • Keep in a cool, dry place away from direct sunlight and excessive heat.
  • Do not freeze unless explicitly permitted by the manufacturer.
  • Keep out of reach of children and unauthorised persons; for professional use only.
  • Use only if the blister and packaging are intact and within the stated expiry date.

Duration

The manufacturer\u2019s material recommends an initial series of 2\u20133 treatments at 1-month intervals, followed by repeat treatment cycles every 3 to 6 months to maintain skin elasticity and hydro-lifting effects. e-FILLERS notes that the duration of results depends on factors such as patient age and lifestyle.

Onset

The official documentation does not specify an exact onset time, but the product is described as providing immediate moisturisation and fine-wrinkle improvement after injection, with optimal rejuvenation developing progressively over the recommended 2\u20133 treatment sessions.

Browse more Skin booster

Top Treatments

Top Cities in the UK